• About us
• Contact

Advertisement

Document › Details

Mologen AG. (12/3/19). "Press Release: Insolvency Filing [Not for publication or distribution in or into US, AU, CA or JP or any jurisdiction in which unlawful]". Berlin.

	Region	Berlin
	Country	Germany
	Organisation	Mologen AG
	Group	Mologen (Group)
	Product	cancer immunotherapy (immuno-oncology, I-O)

Record changed: 2023-06-05

Advertisement

More documents for Mologen (Group)

• [1] Mologen AG. (8/5/19). "Press Release: Mologen AG Announces Top Line Data of Pivotal IMPALA Study in Metastatic Colorectal Cancer. Primary Endpoint Not Met". Berlin....
• [2] Mologen AG. (3/27/19). "Press Release: Top Pharma Manager Stefan M. Manth, MD, to Become CEO of Mologen AG". Berlin....
• [3] Mologen AG. (3/18/19). "Press Release: Early Departure of CEO". Berlin....
• [4] Mologen AG. (1/17/19). "Press Release: Full Placement of Convertible Bond 2019/2027. Total Amount Issued: EUR2.7 Million, Maturity of 8 Years, Coupon of 6% p.a. [NOT FOR US, CA, JP, et al.]". Berlin....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.